Lv7 热心小伙伴
4991 积分 2021-08-06 加入
呱
SOHO State of the Art Updates and Next Questions | Infections in Chronic Lymphocytic Leukemia Patients: Risks and Management
11小时前
已完结
MRD-driven treatment strategies in CLL: Current practice, limitations, and emerging paradigms
14天前
已完结
Measurable Residual Disease in Chronic Lymphocytic Leukemia: Current Understanding and Evolving Role in Clinical Practice
14天前
已完结
Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies
19天前
已完结
Treatment of Elderly Patients With Mantle Cell Lymphoma
21天前
已完结
BTK inhibitors resistance in B cell malignancies: Mechanisms and potential therapeutic strategies
1个月前
已完结
Triplet Therapies in Chronic Lymphocytic Leukemia
1个月前
已完结
Current Treatment of Double Refractory Chronic Lymphocytic Leukemia: A Focus on Novel Drugs
1个月前
已完结
BRUIN 313 and 314 Trials Open the Door for Noncovalent Bruton Tyrosine Kinase Inhibition as Initial Therapy for Chronic Lymphocytic Leukemia
1个月前
已关闭
Optimizing Control Arms in Chronic Lymphocytic Leukemia Clinical Trials: The BRUIN-CLL-321 Trial
1个月前
已完结
皖公网安备34019202002308
